In analogy to known oncofetal tumor markers, such as AFP and Gpc-3, Marquardt et al. [104] established Nope as a new and promising oncofetal surface marker for murine and human HCC and provided evidence for its specific expression in hepatoma cell lines and primary HCC. Here, GPC3 is linked to hepatocellular carcinoma.